# Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

> **NCT02143388** · PHASE3 · COMPLETED · sponsor: **Zhao Chong** · enrollment: 180 (actual)

## Conditions studied

- Local Advanced High Risk Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** IMRT combine with cisplatin concurrent chemotherapy
- **DRUG:** IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT02143388
- **Lead sponsor:** Zhao Chong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-31
- **Primary completion:** 2018-07-27
- **Final completion:** 2022-08-05
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2022-08-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143388, "Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02143388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*